7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde

Basic Information

View in Editor

CAS Number

1071224-34-4

Molecular Formula

C7H3BrN2OS

Molecular Weight

243.08 g/mol

Basic Physical Properties

Physical State

No data available

Melting Point

192.0 to 196.0 deg-C

Boiling Point

355.0±27.0°C at 760 mmHg

Flash Point

168.5±23.7 °C

SMILES

View in Editor

c1cc(c2c(c1C=O)nsn2)Br

InChI

InChI=1S/C7H3BrN2OS/c8-5-2-1-4(3-11)6-7(5)10-12-9-6/h1-3H

InChIKey

VPDPNJVAWKCZEH-UHFFFAOYSA-N

LogP

2.2663

Topological Polar Surface Area

42.85 Å²

Hydrogen Bond Donor/Acceptor

0 / 3

Complexity

192

Safety Information

View Safety Information

Hazard Statement

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

Synonyms & References

English

7-Bromo-benzo[c][1,2,5]thiadiazole-4-carbaldehyde
2,1,3-Benzothiadiazole-4-carboxaldehyde, 7-bromo-
7-Bromo-2,1,3-Benzothiadiazole-4-Carboxaldehyde
7-Bromo-4-formyl-2,1,3-benzothiadiazole
7-Bromobenzo[c][1,2,5]thiadiazole-4-carbaldehyde
7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde
EOS468
VPDPNJVAWKCZEH-UHFFFAOYSA-N
BCP18668
FCH2329882
AK549025
B5433
4-bromo-2,1,3-benzothiadiazole-7-carbaldehyde
7-bromo-ben

MDL Number

MFCD23704428

FAQ

What regulatory guidelines apply to 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde (CAS: 1071224-34-4)?

Regulatory guidelines for 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde (CAS: 1071224-34-4) include GHS classification, REACH regulations, and FDA/EPA requirements. It should be handled in accordance with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for proper hazard communication. Under REACH, it must meet the criteria for identification, classification, and labeling, and may require safety data sheets (SDS). FDA and EPA regulations cover its use in products and environmental protection respectively.

Are there alternatives to 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde in synthesis (CAS: 1071224-34-4)?

Alternatives to 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde in synthesis include other substituted benzothiadiazole derivatives, such as 6-bromo-benzothiadiazole or 8-chloro-benzothiadiazole. Common alternative reagents may include bromine or chlorine for halogenation reactions, or sulfuryl chloride for thioether formation. These alternatives offer similar functional groups but with different substituents, providing flexibility in synthesis.

What is the market or research trend for 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde (CAS: 1071224-34-4)?

Market trends for 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde (CAS: 1071224-34-4) indicate growing interest in its use as a precursor in organic synthesis and pharmaceutical applications. Research is focusing on its potential as a pharmacological agent, particularly in antiviral and anti-inflammatory studies. The demand is influenced by increasing pharmaceutical research and development, with a slight trend towards cost reduction and more sustainable synthesis methods.

How should waste containing 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde (CAS: 1071224-34-4) be handled?

Waste containing 7-Bromo-2,1,3-benzothiadiazole-4-carbaldehyde (CAS: 1071224-34-4) should be collected in a sealed, leak-proof container and disposed of in accordance with local and regional regulations. Incineration is a common method for waste disposal, ensuring complete destruction of the compound. Alternatively, professional waste disposal services can handle the waste safely. Environmental protection precautions include minimizing the release of the compound into the environment and using appropriate personal protective equipment during handling and disposal.